Search research articles
Contact Us
Filters
Showing results (61-70 of 138) with videos related to
Page
of 14
Sort By:
Gynecologic Oncology
|
October 2, 2012
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: a case-control study on survival in patients with two year follow-up
Anna Fagotti, Barbara Costantini, Marco Petrillo, et al.
Gynecologic Oncology
|
November 1, 2011
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study
Gabriella Ferrandina, Giovanna Mantegna, Marco Petrillo, et al.
American Journal of Obstetrics and Gynecology
|
May 28, 2017
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study
Marco Petrillo, Claudia Marchetti, Rossella De Leo, et al.
Vaccines
|
January 30, 2020
Efficacy of HPV Vaccination in Women Receiving LEEP for Cervical Dysplasia: A Single Institution's Experience
Marco Petrillo, Margherita Dessole, Elettra Tinacci, et al.
Oncotarget
|
December 8, 2017
The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer
Simona Leonardi, Marianna Buttarelli, Ilaria De Stefano, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 26, 2016
Quality of Life in Women After Pelvic Exenteration for Gynecological Malignancies: A Multicentric Study
Margherita Dessole, Marco Petrillo, Alessandro Lucidi, et al.
Scientific Reports
|
October 31, 2018
Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6
Marta De Donato, Benedetta Righino, Flavia Filippetti, et al.
American Journal of Obstetrics and Gynecology
|
June 24, 2014
Prognostic role and predictors of complete pathologic response to neoadjuvant chemotherapy in primary unresectable ovarian cancer
Marco Petrillo, Gian Franco Zannoni, Lucia Tortorella, et al.
American Journal of Cancer Research
|
August 14, 2015
Nek6 and Hif-1α cooperate with the cytoskeletal gateway of drug resistance to drive outcome in serous ovarian cancer
Marta De Donato, Mara Fanelli, Marisa Mariani, et al.
Oncotarget
|
July 3, 2015
Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer
Silvia Prislei, Enrica Martinelli, Gian Franco Zannoni, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 138) with videos related to
Sort By:
Page
of 14
Gynecologic Oncology
|
October 2, 2012
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: a case-control study on survival in patients with two year follow-up
Anna Fagotti, Barbara Costantini, Marco Petrillo, et al.
Gynecologic Oncology
|
November 1, 2011
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study
Gabriella Ferrandina, Giovanna Mantegna, Marco Petrillo, et al.
American Journal of Obstetrics and Gynecology
|
May 28, 2017
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study
Marco Petrillo, Claudia Marchetti, Rossella De Leo, et al.
Vaccines
|
January 30, 2020
Efficacy of HPV Vaccination in Women Receiving LEEP for Cervical Dysplasia: A Single Institution's Experience
Marco Petrillo, Margherita Dessole, Elettra Tinacci, et al.
Oncotarget
|
December 8, 2017
The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer
Simona Leonardi, Marianna Buttarelli, Ilaria De Stefano, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 26, 2016
Quality of Life in Women After Pelvic Exenteration for Gynecological Malignancies: A Multicentric Study
Margherita Dessole, Marco Petrillo, Alessandro Lucidi, et al.
Scientific Reports
|
October 31, 2018
Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6
Marta De Donato, Benedetta Righino, Flavia Filippetti, et al.
American Journal of Obstetrics and Gynecology
|
June 24, 2014
Prognostic role and predictors of complete pathologic response to neoadjuvant chemotherapy in primary unresectable ovarian cancer
Marco Petrillo, Gian Franco Zannoni, Lucia Tortorella, et al.
American Journal of Cancer Research
|
August 14, 2015
Nek6 and Hif-1α cooperate with the cytoskeletal gateway of drug resistance to drive outcome in serous ovarian cancer
Marta De Donato, Mara Fanelli, Marisa Mariani, et al.
Oncotarget
|
July 3, 2015
Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer
Silvia Prislei, Enrica Martinelli, Gian Franco Zannoni, et al.
Page
of 14